HCA Holdings Inc (HCA)

NYSE


	Symbol		Exchange		Currency
	HCA		NYSE		USD	Real-time
	1HCA		Milan		EUR	Real-time
	HCA		TradeGate		EUR	Delayed
	H1CA34		B3		BRL	Delayed

Currency in USD

Disclaimer

394.07

+1.61(+0.41%)

Closed05/10

Pre Market

390.40-3.67(-0.93%)

16:52:06

Fair Value

Day's Range

390.40

395.34

52 wk Range

215.96

409.42

HCA Income Statement

Featured here, the Income Statement (earnings report) for HCA Holdings Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

51,336

51,533

58,752

60,233

64,968

Total Revenues Growth

+9.98%

+0.38%

+14.01%

+2.52%

+7.86%

Cost Of Revenues

32,041

32,243

36,260

37,056

39,389

Gross Profit

19,295

19,290

22,492

23,177

25,579

Gross Profit Growth

+10.08%

-0.03%

+16.6%

+3.05%

+10.36%

Gross Profit Margin %

37.59%

37.43%

38.28%

38.48%

39.37%

Other Operating Expenses, Total

12,077

12,028

12,814

14,124

15,952

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10.94%	-0.41%	+6.53%	+10.22%	+12.94%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	855	923	989	976	994
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,626	8,384	8,972	10,179	11,881

Operating Income

7,218

7,262

9,678

9,053

9,627

Operating Income Growth

+8.67%

+0.61%

+33.27%

-6.46%

+6.34%

EBIT Margin %

14.06%

14.09%

16.47%

15.03%

14.82%

Net Interest Expenses

-1,824

-1,584

-1,566

-1,741

-1,938

Net Interest Expenses Growth

-3.93%

+13.16%

+1.14%

-11.17%

-11.32%

Interest Expense, Total

-1,824

-1,584

-1,566

-1,741

-1,938

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

43

54

113

45

22

EBT, Excl. Unusual Items

5,437

5,732

8,225

7,357

7,711

Gain (Loss) On Sale Of Assets

18

-7

1,620

1,301

-5

Other Unusual Items, Total

-211

-295

-12

-78

-

EBT, Incl. Unusual Items

5,244

5,430

9,833

8,580

7,706

EBT, Incl. Unusual Items Growth

-1.71%

+3.55%

+81.09%

-12.74%

-10.19%

EBT, Incl. Unusual Items Margin

10.22%

10.54%

16.74%

14.24%

11.86%

Income Tax Expense

1,099

1,043

2,112

1,746

1,615

Net Income to Company

4,145

4,387

7,721

6,834

6,091

Minority Interest

-640

-633

-765

-1,191

-849

Net Income

3,505

3,754

6,956

5,643

5,242

Net Income Growth

-7.45%

+7.1%

+85.3%

-18.88%

-7.11%

Net Income Margin %

6.83%

7.28%

11.84%

9.37%

8.07%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

3,505

3,754

6,956

5,643

5,242

Basic EPS - Continuing Operations

10.27

11.1

21.51

19.44

19.24

Basic EPS - Continuing Operations Growth

-5.8%

+8.03%

+93.87%

-9.66%

-0.99%

Diluted EPS - Continuing Operations

10.07

10.93

21.16

19.15

18.97

Diluted EPS - Continuing Operations Growth

-5.53%

+8.54%

+93.6%

-9.5%

-0.94%

Basic Weighted Average Shares Outstanding

341.21

338.27

323.32

290.35

272.4

Diluted Weighted Average Shares Outstanding

348.23

343.61

328.75

294.67

276.41

Dividend Per Share

1.6

0.43

1.92

2.24

2.4

Dividend Per Share Growth

+14.29%

-73.13%

+346.51%

+16.67%

+7.14%

EBITDA

9,814

9,983

12,531

12,022

12,704

EBITDA Growth

+10.02%

+1.72%

+25.52%

-4.06%

+5.67%

EBITDA Margin %

19.12%

19.37%

21.33%

19.96%

19.55%

EBIT